{"id":610,"date":"2026-09-29T09:56:14","date_gmt":"2026-09-29T04:26:14","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/"},"modified":"2026-10-05T20:53:01","modified_gmt":"2026-10-05T15:23:01","slug":"glenmark-share-price-today-2026-09-29","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/","title":{"rendered":"Glenmark Pharma Shares Surge 4.98%: Why Glenmark Stock is Rising Today | 29 September 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: GLENMARK<\/strong> \u00b7 29 September 2026 \u00b7 Dated market coverage<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b92,441.50<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>+4.98%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b92,441.50 \/ \u20b92,292.10<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b92,325.70<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>1,258,203<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>29 Sep 2026 \u2022 03:10 PM IST<\/div>\n<\/div>\n<\/div>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\" class=\"wt-card\">\n<div style=\"font-weight:900;color:#1f4d70;margin-bottom:7px;\" class=\"wt-card-title\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;\">\n<li>The stock is +4.98% at \u20b92,441.50.<\/li>\n<li><strong>Likely reason:<\/strong>Strong volume-backed buying and sector outperformance <\/li>\n<li>Approximate traded value is<strong>\u20b9307.19 crore<\/strong>. <\/li>\n<li>It is -3.79% from its 52-week high and +36.20% from its 52-week low.<\/li>\n<li>The stock is being compared with<strong>Nifty Pharma<\/strong>alongside the Nifty 50. <\/li>\n<\/ul><\/div>\n<h2>Why Is Glenmark Pharmaceuticals Share Price Rising Today?<\/h2>\n<p class=\"wt-copy\">Latest NSE EOD report: 2026-09-29. Today&#8217;s Volume: 1,258,203; 5-Day Avg. Volume: 817,296; 20-Day Avg. Volume: 488,980; Volume vs 20-Day Avg.: 2.57x; Delivery Quantity: 839,781; Delivery %: 65.75%; Number of Trades: 56,808.<\/p>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Glenmark Pharmaceuticals shares surged 4.98% to close at \u20b92,441.50 today, trading aggressively near the upper end of its intraday range between \u20b92,292.10 and \u20b92,441.50. Market participation was exceptionally strong, with trading volume clocking over 2.5 times its 20-day average and delivery quantity scaling up to 65.75%, signalling heavy institutional or delivery-based accumulation.<\/p>\n<p class=\"wt-copy\">The stock notably outperformed the broader market and its sectoral peers. While the benchmark Nifty dipped 0.28%, the Nifty Pharma sector index posted a modest 0.64% gain, making Glenmark&#8217;s sharp upward trajectory one of the standout movers in the pharmaceutical space.<\/p>\n<p class=\"wt-copy\">While no single headline-grabbing catalyst dropped today, the stock&#8217;s robust momentum coincides with a series of positive regulatory and operational updates over the past weeks, including the U.S. FDA&#8217;s VAI classification and Establishment Inspection Report (EIR) for its Goa facility, alongside the global expansion of its respiratory footprint with the Ryaltris launch in Brazil.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\" class=\"wt-card\">\n<div style=\"gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\" class=\"wt-card-title\">\n<div style=\"font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p> <span style=\"background:#fff1cf;color:#8a6116;padding:3px 8px;border-radius:999px;font-weight:900;text-transform:uppercase;\">medium confidence<\/span> <\/div>\n<div style=\"font-weight:850;color:#20384a;margin-bottom:7px;\">Strong volume-backed buying and sector outperformance<\/div>\n<div style=\"\">Glenmark rallied sharply by nearly 5% accompanied by massive volume expansion (2.5x of 20-day average) and high delivery percentage, outpacing the broader pharmaceutical index. The move appears supported by recent positive regulatory developments like the U.S. FDA clearance for the Goa plant and institutional accumulation.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Daily return of +4.98% with heavy volumes at 2.57x the 20-day average<\/li>\n<li>High delivery percentage of 65.75% indicating strong institutional interest<\/li>\n<li>Outperformance against Nifty (-0.28%) and Nifty Pharma (+0.64%)<\/li>\n<\/ul><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Research &amp; Brokerage Views<\/h2>\n<div style=\"border:1px solid #cbd8ea;border-radius:12px;padding:14px;background:#f4f8fd;box-sizing:border-box;width:100%;\" class=\"wt-card\">\n<div style=\"width:100%;box-sizing:border-box;border:1px solid #cbd8ea;border-radius:10px;background:#fff;padding:14px 15px;margin-bottom:12px;\">\n<div class=\"wt-broker-row\" style=\"gap:10px;width:100%;box-sizing:border-box;align-items:stretch;\">\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Brokerage<\/div>\n<div style=\"font-weight:800;color:#21384f;\">Motilal Oswal<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">View<\/div>\n<div style=\"font-weight:800;color:#21384f;\">Buy<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Target<\/div>\n<div style=\"font-weight:800;color:#21384f;\">\u20b92,570<\/div>\n<\/p><\/div>\n<div style=\"background:#f4f8fd;border:1px solid #e1e8f1;border-radius:8px;padding:10px 12px;min-width:0;\">\n<div style=\"text-transform:uppercase;letter-spacing:.4px;color:#6d7d90;font-weight:800;margin-bottom:3px;\">Date<\/div>\n<div style=\"font-weight:800;color:#21384f;\">31 Aug 2026<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"margin-top:10px;background:#f8fafc;border:1px solid #e4eaf1;border-radius:8px;padding:11px 12px;\"><strong>Key rationale \/ reported context:<\/strong>Recommended as a stock pick by analyst Chandan Taparia, backed by favorable technical setups and structural business momentum. <\/div>\n<\/p><\/div>\n<p style=\"margin:8px 2px 0;\" class=\"wt-copy\"><em>Brokerage views are third-party opinions and are not WittyTrades recommendations.<\/em><\/p>\n<\/p><\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p class=\"wt-copy\"><strong>Price Position:<\/strong>The stock is near the upper end of the day&#8217;s trading range. <\/p>\n<p class=\"wt-copy\"><strong>Move From Open:<\/strong>+4.24%. <\/p>\n<p class=\"wt-copy\"><strong>Intraday Range:<\/strong>6.42% of the previous close. <\/p>\n<p class=\"wt-copy\"><strong>5-Day Performance:<\/strong>-0.81%; <strong>20-Day Performance:<\/strong>-1.17%. <\/p>\n<\/p><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\" class=\"wt-card\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">US FDA issues EIR with VAI for Goa facility<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">23-Sep-2026<\/div>\n<div style=\"\">Glenmark Pharmaceuticals announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its manufacturing facility located in Goa. The inspection concluded with a Voluntary Action Indicated (VAI) classification, indicating satisfactory regulatory compliance.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>A VAI classification removes key regulatory overhangs for the Goa plant, securing export visibility and smooth operations for key regulated markets. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Global respiratory expansion with Ryaltris launch in Brazil<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">11-Sep-2026<\/div>\n<div style=\"\">The company expanded its international specialty footprint by launching its flagship respiratory product, Ryaltris, in Brazil. This commercial rollout strengthens the company&#8217;s branded respiratory portfolio in key emerging international regions.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Commercializing high-margin specialty products in large international markets drives revenue diversification and supports medium-term margin expansion. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Launch of Calcium Gluconate Injection in the USA<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">21-Aug-2026<\/div>\n<div style=\"\">Glenmark Pharmaceuticals Inc., USA, announced the commercial launch of Calcium Gluconate Injection USP in various dosage formats, including single-dose vials and pharmacy bulk packages. This portfolio addition strengthens the company&#8217;s institutional injectables segment in North America.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Expands the complex generics portfolio in the highly lucrative US market, supporting steady revenue generation. <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Execution of newly launched products in the US and Latin American markets<\/li>\n<li>Regulatory updates regarding other manufacturing plants and pending approvals<\/li>\n<li>Price action relative to the 52-week high of \u20b92,537.60<\/li>\n<\/ul>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\" class=\"wt-copy\"><strong>Catalyst note:<\/strong>There is no single same-day trigger announced today, but the sharp rally is backed by heavy volume accumulation and sustained positive operational catalysts. <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p class=\"wt-copy\">Glenmark rallied sharply by nearly 5% accompanied by massive volume expansion (2.5x of 20-day average) and high delivery percentage, outpacing the broader pharmaceutical index. The move appears supported by recent positive regulatory developments like the U.S. FDA clearance for the Goa plant and institutional accumulation.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p class=\"wt-copy\">Today&#8217;s volume is 1,258,203. The latest 20-day average available is 488,980, equivalent to about 2.57x of the recent average.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p class=\"wt-copy\">Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the<a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>. <\/p>\n<div class=\"witty-related\"><\/div>\n<p><strong>Article by:<\/strong><a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><\/p>\n<div class=\"witty-disclaimer\"><strong>Disclaimer:<\/strong>Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors. This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security. Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions. <\/div>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-10-05\/\">Why Glenmark Shares Fell 1.54% Today: Sector Consolidation \u2014 5 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-30\/\">Why Glenmark Shares Fell 4.4% Today: Sector Headwinds &amp; Volume Analysis \u2014 30 September 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/glenmark\/\">More Glenmark Pharmaceuticals news and dated analysis \u2192<\/a><\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/\"}, \"headline\": \"Glenmark Pharma Shares Surge 4.98%: Why Glenmark Stock is Rising Today | 29 September 2026\", \"description\": \"Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.\", \"datePublished\": \"2026-09-29T04:26:14Z\", \"dateModified\": \"2026-10-05T14:43:53.354897+00:00\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/glenmark-company-news-2026-09-29.jpg\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.<\/p>\n","protected":false},"author":1,"featured_media":3385,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Glenmark Pharma Shares Surge 4.98%: Why Glenmark Stock is Rising Today | 29 September 2026","_witty_meta_description":"Glenmark Pharmaceuticals shares jumped nearly 5% with heavy volume. Check out key catalysts, sector comparison, and stock analysis on WittyTrades.","_witty_primary_phrase":"Glenmark Pharmaceuticals share price 2026-09-29","_witty_reason_label":"Strong volume-backed buying and sector outperformance","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[37],"class_list":["post-610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-glenmark"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":3,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610\/revisions"}],"predecessor-version":[{"id":3387,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/610\/revisions\/3387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/3385"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}